Charles River EVP Creamer gets stock from PSU vesting

Charles River Laboratories International executive Victoria L. Creamer reported stock transactions involving company common shares.

Accepted by SEC EDGAR 02/03/2026 - 04:33 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Charles River Laboratories International executive Victoria L. Creamer reported stock transactions involving company common shares. On 01/30/2026, she acquired 5,006 shares of common stock at a price of $0, following the achievement of performance goals under performance share unit awards originally granted on May 26, 2023.

On the same date, she disposed of 1,296 common shares at a price of $211.68 per share. After these transactions, she directly owned 26,072 shares of Charles River Laboratories common stock in her capacity as EVP & Chief People Officer.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Creamer Victoria L

Role EVP & Chief People Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,006	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	1,296	$211.68	$274K

Holdings After Transaction: Common Stock — 26,072 shares (Direct)

Footnotes (1)

1. F1. Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 26, 2023.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Victoria L. Creamer report for Charles River (CRL)?

Victoria L. Creamer reported acquiring 5,006 Charles River common shares and disposing of 1,296 shares on January 30, 2026. These transactions were reported on a Form 4 and reflect changes in her direct ownership position as an executive officer.

How many Charles River (CRL) shares does Victoria L. Creamer own after this Form 4?

After the reported transactions, Victoria L. Creamer directly owns 26,072 shares of Charles River common stock. This figure reflects her holdings following the 5,006-share acquisition at $0 and the 1,296-share disposition at $211.68 per share.

What triggered the 5,006-share issuance reported by Victoria L. Creamer at Charles River (CRL)?

The 5,006 shares of Charles River common stock were issued after performance goals were achieved under performance share unit awards granted on May 26, 2023. This issuance reflects the vesting outcome once those pre-set performance conditions were met.

What were the prices involved in Victoria L. Creamer’s Charles River (CRL) stock transactions?

Victoria L. Creamer acquired 5,006 Charles River common shares at a price of $0 per share and disposed of 1,296 shares at $211.68 per share. Both transactions occurred on January 30, 2026, according to the Form 4 filing.

What is Victoria L. Creamer’s role at Charles River (CRL) in this Form 4 filing?

In this Form 4, Victoria L. Creamer is identified as an officer of Charles River Laboratories, serving as EVP & Chief People Officer. The filing reports changes in her directly held common stock as part of her executive compensation-linked holdings.

Does the Form 4 for Charles River (CRL) involve derivative securities?

The provided Form 4 excerpt lists only non-derivative common stock transactions for Victoria L. Creamer. It shows an acquisition of 5,006 shares and a disposition of 1,296 shares, with no derivative securities reported in the visible portion of the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Creamer Victoria L

(Last) (First) (Middle)

C/O CHARLES RIVER LABORATORIES

251 BALLARDVALE STREET

(Street)

WILMINGTON MA 01887

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. [ CRL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief People Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/30/2026		A		5,006(1)	A	$0	27,368	D
Common Stock	01/30/2026		F		1,296	D	$211.68	26,072	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 26, 2023.

	/s/ Victoria L. Creamer	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.